跳至主要内容
临床试验/NCT03645525
NCT03645525撤回1 期

Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD)

Children's Hospital of Fudan University3 个研究点 分布在 1 个国家开始时间: 2019年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
试验地点
3
主要终点
Oxygen requirement 3 days after transplantation

研究概览

简要总结

Umbilical Cord-derived Mesenchymal stem cell has been proven effective in the experimental bronchopulmonary dysplasia (BPD).A multi-center study was designed to evaluate the safety and efficacy of the cellular therapy in extremely preterm infants at high risk for BPD.

详细描述

Brochopulmonary dysplasia is a severe chronic lung disease in extremely preterm infants. The morbidity of BPD is increasing in CHINA. The preventive and therapy methods of BPD are still lacking.

Umbilical Cord-derived Mesenchymal stem cell has been proven effective in the experimental bronchopulmonary dysplasia (BPD). A multi-center study was designed to evaluate the safety and efficacy of the cellular therapy in extremely preterm infants at high risk for BPD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Weeks 至 3 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Extremely preterm infants who remain on mechanic ventilator after 2 weeks of postnatal age
  • Extremely preterm infants with a X-ray sign of BPD after 2 weeks of postnatal age

排除标准

  • Patients with severe congenital diseases
  • Patients with IVH more than 3 grade
  • Patients with severe sepsis
  • Patients with active pulmonary hemorrhage

研究组 & 干预措施

Mesenchymal stem cell

Experimental

Human Umbilical Cord-derived Mesenchymal stem cell in the saline

干预措施: Human Umbilical Cord-derived Mesenchymal stem cell (Drug)

placebo

Placebo Comparator

saline without mesenchymal stem cell

干预措施: placebo (Drug)

结局指标

主要结局

Oxygen requirement 3 days after transplantation

时间窗: 3 days

Temporal profiles of the fraction of inspiration oxygen 3 days after transplantation, the tolerable required oxygen ,which is the minimum fraction of inspiration oxygen in which the participants has a stable SpO2 (90%-95%), measured in %

次要结局

  • Oxygen requirement 7 days after transplantation(7 days)
  • Duration of ventilator dependence(up to 36 weeks PMA)
  • Incidence of severe BPD(up to 36 weeks PMA)
  • Survival rate(up to 36 weeks PMA)
  • Temperature(3 days)
  • Heart rate(3 days)
  • Respiratory rate(3 days)
  • Duration of CPAP treatment(up to 36 weeks PMA)
  • Percentage of participants treated with steroids for weaning from ventilator(up to 36 weeks PMA)
  • Growth velocity (Z-score)(up to 36 weeks PMA)
  • bronohoalveolar lavage (BAL) cytokine level(7 days)
  • The severity of BPD in X-ray patterns(7 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验